Sorry, you need to enable JavaScript to visit this website.

Skip to main content


Focus on Mood Disorders

Mood Disorders
Our Areas of Interest for Collaboration
Depression and Treatment-Resistant DepressionBipolar DepressionBiomarkers and Integrated Solutions
  • Novel therapeutic agents that have fast onset of action, good safety and tolerability profiles and that address common co-morbidities (for example, anxiety and substance abuse)
    • Glutamatergic agents
    • Neuroactive cytokines
    • Molecules that positively impact synaptic plasticity and cellular resilience
  • Phase 2 and later-stage opportunities with defined mechanism of action and superior efficacy over standard of care
  • Novel therapeutic agents that provide rapid improvement in bipolar depression and in suicidal patients and that produce long-term stabilization of mood and prevent recurrences
  • Predictive biomarkers of response to antidepressants
  • Biomarkers for relapse prediction
  • Diagnostic biomarkers to identify subgroups with different etiologies



Nerve fibers
Nerve fibers